COVID-19
The risk of viral transmissions from domestic and wild animals to humans is a pressing concern for human health, as humans can also transmit viral infections back to domestic and wild animals, potentially leading to the emergence of epidemic diseases. Studies have shown that the Severe Acute Respiratory Syndrome Coronavirus
COVID-19
Researchers at the University of Kentucky have published a study reviewing the endocrine consequences of COVID-19, including diabetes, thyroid dysfunction, adrenal, and pituitary disorders. The study found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to thyroid dysfunction and long-term sequelae. The researchers propose a preventive approach
COVID-19
A study published in Frontiers in Microbiology reveals significant changes in microbial compositions in raw sewage during the COVID-19 pandemic. The study, conducted at the University of Tennessee, Knoxville, analyzed wastewater samples collected from six dormitories over a one-year period. The researchers detected the presence of SARS-CoV-2 RNA in sewage
COVID-19
Investigative researchers at the University of Washington have made a groundbreaking discovery in the fight against COVID-19. According to their study, the SARS-CoV-2 virus uses its non-structural protein 1 (nsp1) to evade the host's immune system by inhibiting translation in human cells. This mechanism remains elusive in other
COVID-19
Researchers have identified new data highlighting the potential of cannabinoids as treatments for COVID-19, emphasizing the need for novel approaches to combat the virus. According to a study published in the Journal of Molecular Structure, investigators used molecular docking and simulation techniques to explore the interaction between cannabinoids and SARS-CoV-2
COVID-19
New research reveals that SARS-CoV-2 infection causes not only respiratory tract damage but also has significant systemic implications, affecting multiple body systems including the gastrointestinal, neurological, cardiovascular, ocular, and renal systems. The virus, which caused a global public health crisis, has shown a high degree of genomic similarity to SARS-CoV
COVID-19
Researchers from Medicago Inc. have made a groundbreaking discovery in the production of COVID-19 vaccines. By expressing the Spike (S) protein of Severe Acute Respiratory Syndrome Coronavirus 2 in agroinfiltrated leaves of Nicotiana benthamiana, they found that the production of coronavirus-like particles (CoVLPs) can be achieved. However, this process triggers
COVID-19
Researchers at the University of California have published new findings on the infection dynamics and pathogenesis of COVID-19 variants in mice. According to the study, six SARS-CoV-2 variants were assessed, including B.1 (WA1-like), alpha, beta, delta, omicron, and omicron XBB.1.5. The study found that mice infected with
COVID-19
A recent preprint abstract from medrxiv.org sheds light on the COVID-19 crisis in Brazil, revealing structural inequalities and significant variant-related differences in the progression of the pandemic. The study, focusing on a five-year period from January 2020 to December 2024, analyzed 47.5 million influenza-like illness cases, 2.1
COVID-19
Scientists at Hokkaido University have made significant advancements in developing an effective COVID-19 inactivated whole virus particle (WPV) vaccine. The research team, led by Toshiki Sekiya, was able to optimize the preparation method to preserve the structural integrity of the virus particle, which is crucial for inducing effective immunity against
COVID-19
Researchers at the University of Wellington have patented a novel fusion polypeptide designed to provide effective SARS-CoV-2 vaccination. The polypeptide, which consists of a fusion of the SARS-CoV-2 Spike protein receptor binding domain and the N-terminal domain, is aimed at preventing and treating SARS-CoV-2 infection. The fusion polypeptide is designed
COVID-19
The Covid-19 pandemic continues to unfold, with a new variant, LP.8.1, rapidly spreading across the globe. This new strain, which originated from the JN.1 Omicron strain of Covid, has been detected in 23 countries, including the UK, where it now accounts for over 60% of all Covid
